Insider · CIK 0002106955
Joseph Michael Casper
Files at NRXP (NRX Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Joseph Michael Casper files SEC Form 4 as COO at NRXP (NRX Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joseph Michael Casper has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | NRXP NRX Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Feb 17, 2026 |
Questions about Joseph Michael Casper
Answered from the filings on this page, as of the latest one.
Is Joseph Michael Casper buying or selling?
Joseph Michael Casper has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joseph Michael Casper's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph Michael Casper has 0.
Where does Joseph Michael Casper file Form 4?
Joseph Michael Casper has filed Form 4 at NRXP (NRX Pharmaceuticals, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.